Literature DB >> 1514167

Granulocyte elastase, tumor necrosis factor-alpha and urokinase levels as prognostic markers in severe infection.

J Philippé1, G Dooijewaard, F Offner, P Turion, G Baele, G Leroux-Roels.   

Abstract

We have examined the prognostic value of the levels in the blood of granulocyte elastase-alpha 1-proteinase inhibitor (E-alpha 1-PI) complex, tumor necrosis factor-alpha (TNF-alpha) and urokinase-type plasminogen activator (u-PA) in 35 patients with severe infection upon admission to an Intensive Care Unit. Fourteen patients died. No differences for E-alpha 1-PI complex were found between survivors and nonsurvivors, but in all patients the levels on admission were eight-fold higher than the reference value. TNF-alpha levels, measured by immunoassay, on admission were four times higher in the nonsurvivors than in the survivors (p = 0.0003) and correlated with the severity of the disease (APACHE II score, r = 0.43, p less than 0.05). TNF-alpha was not detectable by bioassay. Total u-PA antigen (u-PA Ag), plasmin-activatable single-chain u-PA (scu-PA) and inactive, nonactivatable u-PA (u-PA#) were on admission all two-fold higher in the nonsurvivors (p = 0.0006, 0.003 and 0.0003, respectively), while normal in the survivors. In both, survivors and nonsurvivors, the ratio between scu-PA and u-PA Ag was significantly decreased (p less than 0.001, compared to a reference group of healthy volunteers), indicative for enhanced conversion of scu-PA to active two-chain u-PA (tcu-PA) and inactive u-PA# during severe infectious disease. tcu-PA was detected in nine of the 35 patients, while virtually undetectable in controls. scu-PA correlated with the Child-Pugh score on admission (r = 0.42, p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1514167

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

Review 1.  Time course of cytokine levels in sepsis.

Authors:  L G Thijs; C E Hack
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

2.  Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA.

Authors:  M A Haj; L A Robbie; A Croll; G D Adey; B Bennett
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

3.  Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood.

Authors:  D Menzel; M Levi; G Dooijewaard; M Peters; J W ten Cate
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

4.  Monocyte adhesion molecules expression in patients with chronic hepatitis C liver disease.

Authors:  Nora E I El-Bassiouni; Ola M Mahmoud; Eman G El Ahwani; Raafat A Ibrahim; Azza E I El Bassiouny
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.